2022
DOI: 10.1186/s12876-022-02130-2
|View full text |Cite
|
Sign up to set email alerts
|

The global, regional and national burden of peptic ulcer disease from 1990 to 2019: a population-based study

Abstract: Background Peptic ulcer disease (PUD) is a common digestive disorder, of which the prevalence decreased in the past few decades. However, the decreasing tendency has plateaued in recent years due to changes in risk factors associated with the etiology of PUD, such as non-steroidal anti-inflammatory drug use. In this study, we investigated the epidemiological and the sociodemographic characteristics of PUD in 204 countries and territories from 1990 to 2019 based on data from the Global Burden of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

3
84
0
3

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 112 publications
(90 citation statements)
references
References 59 publications
3
84
0
3
Order By: Relevance
“…Young age-group distribution is commonly seen in the developing world, which is mostly predisposed by smoking. With the advanced age in developed countries, these patients tend to be elderly with multiple comorbidities and associated use of NSAIDs, Helicobacter pylori, physiological stress, corticosteroids, and previous history of PUD are risks factors for PUP [ 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Young age-group distribution is commonly seen in the developing world, which is mostly predisposed by smoking. With the advanced age in developed countries, these patients tend to be elderly with multiple comorbidities and associated use of NSAIDs, Helicobacter pylori, physiological stress, corticosteroids, and previous history of PUD are risks factors for PUP [ 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Gastric ulcer (GU) disease affects about 10% of the population [ 1 , 4 ]. Several classes of drugs are used in GU treatment: proton pump inhibitors, M1-receptor blockers, and H2-receptor antagonists.…”
Section: Introductionmentioning
confidence: 99%
“…Otherwise, the infection by Helicobacter pylori is also linked to ulcer gastric and gastric cancer [3]. According to Xie et al [4], the global prevalence of PUD was approximately 8.09 million in 2019, which represents 25.82% more than in 1990. Furthermore, the south Asia region had the highest age-standardized prevalence rate in PUD with 156.62 (130.58-187.05) per 100,000 population.…”
Section: Introductionmentioning
confidence: 99%